<?xml version="1.0" encoding="UTF-8"?>
<p>This narrative concerning the relative importance of human-to-human transmission for LASV, however, requires re-evaluation as there are important indications of human-to-human transmission. More precisely, one of the early nosocomial outbreaks, in Jos, Nigeria (see 
 <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, 
 <xref ref-type="fig" rid="pntd-0003398-g001">Fig. 1</xref> and also the Supporting Information, 
 <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>) was triggered by an index case that transmitted to possibly 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e008.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> others in the hospital, with no indication of iatrogenic transfer. Further cases of extra-hospital transmission within a single family (five from the same family, 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e009.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula>, 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e010.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula>, 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e011.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula>, 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e012.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula>, and 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e013.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> who likely initiated the chain) were reported, here and throughout we refer to this chain as an ‘extra-nosocomial’ chain. Haas 
 <italic>et al.</italic>
 <xref rid="pntd.0003398-Haas1" ref-type="bibr">[14]</xref> investigated secondary transmission after an imported case of LF into Europe and found that one of 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e014.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> contacts that were tested serologically, a physician who examined the patient on day 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e015.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> of illness, had become infected. The authors concluded that, during the initial phase of symptomatic LF the risk of transmission is low, but it may increase with progression of disease and increasing viral excretion. Emond 
 <italic>et al.</italic>
 <xref rid="pntd.0003398-Emond1" ref-type="bibr">[15]</xref> described a case of LF in the UK in which the virus was isolated from urine 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e016.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> days after the acute phase had ended, despite not being detected earlier. The virus may also be found in pharyngeal secretions for 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e017.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> weeks after the onset of clinical signs 
 <xref rid="pntd.0003398-Monath3" ref-type="bibr">[16]</xref>. In an experimental model, Stephenson 
 <italic>et al.</italic>
 <xref rid="pntd.0003398-Stephenson1" ref-type="bibr">[17]</xref> showed the ability to infect guinea pigs and cynomolgus monkeys with LASV via the respiratory route and Peters 
 <italic>et al.</italic>
 <xref rid="pntd.0003398-Peters1" ref-type="bibr">[18]</xref> demonstrated fatal LASV transmission to monkeys through being held in the same room for 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e018.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> days with inoculated rodents. Sagripanti 
 <italic>et al.</italic>
 <xref rid="pntd.0003398-Sagripanti1" ref-type="bibr">[19]</xref>, in a dark room at ambient laboratory temperatures controlled between 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e019.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> and 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e020.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> and 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e021.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> relative humidity, showed that the time required for a 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e022.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> reduction in viral load of LASV in glass containers was 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e023.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> hours and was 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e024.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> days for a 
 <inline-formula>
  <inline-graphic xlink:href="pntd.0003398.e025.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </inline-formula> relative humidity. Also, Kernéis 
 <italic>et al.</italic>
 <xref rid="pntd.0003398-Kernis1" ref-type="bibr">[20]</xref> identified that risk factors for positive seroconversion to LASV included either having received a medical injection, or having lived with someone displaying a haemorrhage, in the previous twelve months. No factors related to contact with rodents were identified. Similarly, McCormick 
 <italic>et al.</italic>
 <xref rid="pntd.0003398-McCormick1" ref-type="bibr">[21]</xref> reported a lack of correlation between human LASV-specific IgG prevalence and either the level of domestic infestation by 
 <italic>Mastomys</italic>, or the presence of LASV infection in 
 <italic>Mastomys</italic>. These observations, taken together, suggest that a significant (if perhaps variable) proportion of the burden of LF might be associated with human-to-human transmission.
</p>
